SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-14-406416
Filing Date
2014-11-12
Accepted
2014-11-10 17:31:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d815556d424b5.htm 424B5 513454
2 GRAPHIC g815556g34s30.jpg GRAPHIC 17604
3 GRAPHIC g815556g80s39.jpg GRAPHIC 8296
  Complete submission text file 0001193125-14-406416.txt   550512
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-183037 | Film No.: 141210011
SIC: 2834 Pharmaceutical Preparations